151 related articles for article (PubMed ID: 17314275)
1. Nuclear localization of the parafibromin tumor suppressor protein implicated in the hyperparathyroidism-jaw tumor syndrome enhances its proapoptotic function.
Lin L; Czapiga M; Nini L; Zhang JH; Simonds WF
Mol Cancer Res; 2007 Feb; 5(2):183-93. PubMed ID: 17314275
[TBL] [Abstract][Full Text] [Related]
2. Defective nucleolar localization and dominant interfering properties of a parafibromin L95P missense mutant causing the hyperparathyroidism-jaw tumor syndrome.
Panicker LM; Zhang JH; Dagur PK; Gastinger MJ; Simonds WF
Endocr Relat Cancer; 2010 Jun; 17(2):513-24. PubMed ID: 20304979
[TBL] [Abstract][Full Text] [Related]
3. Identification of a functional bipartite nuclear localization signal in the tumor suppressor parafibromin.
Hahn MA; Marsh DJ
Oncogene; 2005 Sep; 24(41):6241-8. PubMed ID: 16116486
[TBL] [Abstract][Full Text] [Related]
4. Parafibromin, product of the hyperparathyroidism-jaw tumor syndrome gene HRPT2, regulates cyclin D1/PRAD1 expression.
Woodard GE; Lin L; Zhang JH; Agarwal SK; Marx SJ; Simonds WF
Oncogene; 2005 Feb; 24(7):1272-6. PubMed ID: 15580289
[TBL] [Abstract][Full Text] [Related]
5. The HRPT2 tumor suppressor gene product parafibromin associates with human PAF1 and RNA polymerase II.
Yart A; Gstaiger M; Wirbelauer C; Pecnik M; Anastasiou D; Hess D; Krek W
Mol Cell Biol; 2005 Jun; 25(12):5052-60. PubMed ID: 15923622
[TBL] [Abstract][Full Text] [Related]
6. The parafibromin tumor suppressor protein inhibits cell proliferation by repression of the c-myc proto-oncogene.
Lin L; Zhang JH; Panicker LM; Simonds WF
Proc Natl Acad Sci U S A; 2008 Nov; 105(45):17420-5. PubMed ID: 18987311
[TBL] [Abstract][Full Text] [Related]
7. HRPT2, a tumor suppressor gene for hyperparathyroidism-jaw tumor syndrome.
Wang PF; Tan MH; Zhang C; Morreau H; Teh BT
Horm Metab Res; 2005 Jun; 37(6):380-3. PubMed ID: 16001331
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical assessment of parafibromin in mouse and human tissues.
Porzionato A; Macchi V; Barzon L; Masi G; Iacobone M; Parenti A; Palù G; De Caro R
J Anat; 2006 Dec; 209(6):817-27. PubMed ID: 17118068
[TBL] [Abstract][Full Text] [Related]
9. Parafibromin is a nuclear protein with a functional monopartite nuclear localization signal.
Bradley KJ; Bowl MR; Williams SE; Ahmad BN; Partridge CJ; Patmanidi AL; Kennedy AM; Loh NY; Thakker RV
Oncogene; 2007 Feb; 26(8):1213-21. PubMed ID: 16964291
[TBL] [Abstract][Full Text] [Related]
10. Nucleolar localization of parafibromin is mediated by three nucleolar localization signals.
Hahn MA; Marsh DJ
FEBS Lett; 2007 Oct; 581(26):5070-4. PubMed ID: 17923126
[TBL] [Abstract][Full Text] [Related]
11. Tumor suppressor gene mutation in a patient with a history of hyperparathyroidism-jaw tumor syndrome and healed generalized osteitis fibrosa cystica: a case report and genetic pathophysiology review.
Parfitt J; Harris M; Wright JM; Kalamchi S
J Oral Maxillofac Surg; 2015 Jan; 73(1):194.e1-9. PubMed ID: 25511968
[TBL] [Abstract][Full Text] [Related]
12. Parafibromin--functional insights.
Newey PJ; Bowl MR; Thakker RV
J Intern Med; 2009 Jul; 266(1):84-98. PubMed ID: 19522828
[TBL] [Abstract][Full Text] [Related]
13. Parafibromin inhibits cancer cell growth and causes G1 phase arrest.
Zhang C; Kong D; Tan MH; Pappas DL; Wang PF; Chen J; Farber L; Zhang N; Koo HM; Weinreich M; Williams BO; Teh BT
Biochem Biophys Res Commun; 2006 Nov; 350(1):17-24. PubMed ID: 16989776
[TBL] [Abstract][Full Text] [Related]
14. CDC73/HRPT2 CpG island hypermethylation and mutation of 5'-untranslated sequence are uncommon mechanisms of silencing parafibromin in parathyroid tumors.
Hahn MA; Howell VM; Gill AJ; Clarkson A; Weaire-Buchanan G; Robinson BG; Delbridge L; Gimm O; Schmitt WD; Teh BT; Marsh DJ
Endocr Relat Cancer; 2010 Mar; 17(1):273-82. PubMed ID: 20026646
[TBL] [Abstract][Full Text] [Related]
15. The parafibromin tumor suppressor protein is part of a human Paf1 complex.
Rozenblatt-Rosen O; Hughes CM; Nannepaga SJ; Shanmugam KS; Copeland TD; Guszczynski T; Resau JH; Meyerson M
Mol Cell Biol; 2005 Jan; 25(2):612-20. PubMed ID: 15632063
[TBL] [Abstract][Full Text] [Related]
16. Characterization of a novel CDC73 gene mutation in a hyperparathyrodism-jaw tumor patient affected by parathyroid carcinoma in the absence of somatic loss of heterozygosity.
Ciuffi S; Cianferotti L; Nesi G; Luzi E; Marini F; Giusti F; Zonefrati R; Gronchi G; Perigli G; Brandi ML
Endocr J; 2019 Apr; 66(4):319-327. PubMed ID: 30799315
[TBL] [Abstract][Full Text] [Related]
17. Parafibromin mutations in hereditary hyperparathyroidism syndromes and parathyroid tumours.
Bradley KJ; Cavaco BM; Bowl MR; Harding B; Cranston T; Fratter C; Besser GM; Conceição Pereira M; Davie MW; Dudley N; Leite V; Sadler GP; Seller A; Thakker RV
Clin Endocrinol (Oxf); 2006 Mar; 64(3):299-306. PubMed ID: 16487440
[TBL] [Abstract][Full Text] [Related]
18. Cytoplasmic polyadenylation element binding protein is a conserved target of tumor suppressor HRPT2/CDC73.
Zhang JH; Panicker LM; Seigneur EM; Lin L; House CD; Morgan W; Chen WC; Mehta H; Haj-Ali M; Yu ZX; Simonds WF
Cell Death Differ; 2010 Oct; 17(10):1551-65. PubMed ID: 20339377
[TBL] [Abstract][Full Text] [Related]
19. Loss of nuclear expression of parafibromin distinguishes parathyroid carcinomas and hyperparathyroidism-jaw tumor (HPT-JT) syndrome-related adenomas from sporadic parathyroid adenomas and hyperplasias.
Gill AJ; Clarkson A; Gimm O; Keil J; Dralle H; Howell VM; Marsh DJ
Am J Surg Pathol; 2006 Sep; 30(9):1140-9. PubMed ID: 16931959
[TBL] [Abstract][Full Text] [Related]
20. The tumor suppressor parafibromin is required for posttranscriptional processing of histone mRNA.
Farber LJ; Kort EJ; Wang P; Chen J; Teh BT
Mol Carcinog; 2010 Mar; 49(3):215-23. PubMed ID: 19908240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]